|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00950 LEE'S PHARM
Nominal 
1.220 +0.020 (+1.667%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 0.589% | 1.598% | 57.684% | 3.752% | 3.778% |
| ROAE (%) | 0.843% | 2.337% | 86.130% | 5.818% | 5.572% |
| Return on Capital Employed (%) | 0.745% | 2.406% | 73.211% | 5.601% | 4.596% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 52.355% | 62.503% | 63.680% | 64.195% | 65.489% |
| EBITDA Margin (%) | 18.187% | 18.381% | 167.399% | 22.220% | 18.421% |
| Pre-tax Profit Margin (%) | 2.923% | 5.503% | 155.539% | 11.016% | 10.082% |
| Net Profit Margin (%) | 1.586% | 4.159% | 156.945% | 10.628% | 10.300% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.012 X | 1.002 X | 1.044 X | 1.313 X | 1.586 X |
| Quick Ratio (X) | 0.553 X | 0.619 X | 0.685 X | 0.874 X | 1.305 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 32.175% | 33.770% | 34.253% | 34.970% | 31.943% |
| Total Debt / Total Assets (%) | 7.062% | 5.877% | 7.345% | 4.817% | 4.614% |
| Net Debt / Total Assets (%) | 1.146% | -0.928% | -0.286% | -6.717% | -5.413% |
| Total Debt / Shareholders' Funds (%) | 10.012% | 8.497% | 10.839% | 7.289% | 7.315% |
| Long Term Debt / Shareholders' Funds (%) | 3.657% | 4.154% | 3.731% | 0.349% | 0.582% |
| Net Debt / Shareholders' Funds (%) | 1.625% | -1.341% | -0.422% | -10.163% | -8.583% |
| Net Cash / (Debt) ($) | (33.140M) | 25.807M | 10.391M | 218.492M | 197.051M |
| Net Cash / (Debt) per share ($) | (0.056) | 0.044 | 0.018 | 0.372 | 0.335 |
| Total Debt / Capital Employed (%) | 9.106% | 7.669% | 9.842% | 6.787% | 6.148% |
| Interest Coverage Ratio (X) | 3.730 X | 11.252 X | 448.177 X | 25.891 X | 22.338 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 199.089 Day | 229.161 Day | 295.958 Day | 280.657 Day | 202.718 Day |
| Receivables Turnover (Day) | 33.946 Day | 41.380 Day | 47.262 Day | 46.890 Day | 45.296 Day |
| Payables Turnover (Day) | 30.407 Day | 24.256 Day | 19.650 Day | 23.081 Day | 21.893 Day |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 62,478,000 |
| %Change | 287.653% |
| EPS / (LPS) | HKD 0.106 |
| NBV Per Share ($) | HKD 2.910 |